 BOTHELL, Wash., Aug. 25, 2021 PRNewswire -- BioLife Solutions , Inc. Nasdaq: BLFS BioLife or the Company, a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that its common stock will be added to the SP SmallCap 600 Index effective prior to the opening of trading on Monday, August 30, 2021. 